Russell P Rother Selected Research

Hemoglobinuria

5/2009	Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.
4/2004	A novel mechanism of complement-independent clearance of red cells deficient in glycosyl phosphatidylinositol-linked proteins.
2/2004	Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Russell P Rother Research Topics

Disease

12	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 08/2010 - 02/2004
11	Hemolysis 05/2010 - 02/2004
3	Hemolytic Anemia 04/2010 - 04/2004
3	Hemoglobinuria 05/2009 - 02/2004
3	Anemia 05/2009 - 04/2005
3	Fatigue 06/2008 - 09/2006
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017 - 04/2005
2	Guillain-Barre Syndrome 07/2010 - 05/2008
2	Pulmonary Hypertension 05/2010 - 04/2005
2	Thrombosis (Thrombus) 05/2009 - 10/2007
2	Reperfusion Injury 06/2007 - 07/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2007 - 07/2005
1	Pain (Aches) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Chronic Renal Insufficiency 08/2010
1	Right Ventricular Dysfunction 05/2010
1	Hypertension (High Blood Pressure) 05/2010
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 05/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2009
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 04/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2009
1	Atherosclerosis 02/2009
1	Atypical Hemolytic Uremic Syndrome 01/2009
1	Paralysis (Palsy) 05/2008
1	Respiratory Paralysis 05/2008
1	Miller Fisher Syndrome (Fisher Syndrome) 05/2008
1	Thrombocytopenia (Thrombopenia) 02/2008
1	Myasthenia Gravis 12/2007
1	Muscle Weakness 12/2007
1	Neuromuscular Junction Diseases 12/2007
1	Thromboembolism 12/2007
1	Ischemia 06/2007
1	Chronic Disease (Chronic Diseases) 09/2006
1	Neoplasms (Cancer) 09/2006
1	Dystonia (Limb Dystonia) 12/2005
1	Inflammation (Inflammations) 07/2005
1	Lung Injury 05/2005

Drug/Important Bio-Agent (IBA)

15	eculizumab FDA Link 08/2010 - 02/2004
12	Complement System Proteins (Complement)IBA 04/2010 - 02/2004
6	Complement Inactivating AgentsIBA 08/2010 - 09/2006
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2010 - 10/2005
2	AntibodiesIBA 07/2010 - 05/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2010 - 04/2005
2	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 05/2009 - 11/2007
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2007 - 02/2004
1	P-SelectinIBA 01/2017
1	crizanlizumabIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 07/2010
1	pro-brain natriuretic peptide (1-76)IBA 05/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2010
1	Arginine (L-Arginine)FDA Link 05/2010
1	HaptoglobinsIBA 04/2010
1	Proteins (Proteins, Gene)FDA Link 05/2009
1	Apolipoproteins E (ApoE)IBA 02/2009
1	ApolipoproteinsIBA 02/2009
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 02/2009
1	GangliosidesIBA 05/2008
1	AutoantibodiesIBA 12/2007
1	Cholinergic ReceptorsIBA 12/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	Peptides (Polypeptides)IBA 06/2007
1	Interleukin-6 (Interleukin 6)IBA 06/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 06/2007
1	FibrinIBA 06/2007
1	CytokinesIBA 06/2007
1	Monoclonal AntibodiesIBA 09/2006
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 07/2005
1	LectinsIBA 07/2005
1	FicolinsIBA 05/2005
1	Hemoglobins (Hemoglobin)IBA 04/2005
1	Hemoglobin AIBA 04/2005

Therapy/Procedure

3	Therapeutics 01/2017 - 12/2005
1	Liver Transplantation 05/2009
1	Intravenous Injections 05/2008
1	Intraperitoneal Injections 05/2008